株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

新型コロナウイルス感染症(COVID-19)のデジタルPCR(dPCR)業界への影響

Impact of COVID-19 on Global Digital PCR Industry

発行 Orion Market Research Pvt Ltd 商品コード 931564
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。
新型コロナウイルス感染症(COVID-19)のデジタルPCR(dPCR)業界への影響 Impact of COVID-19 on Global Digital PCR Industry
出版日: 2020年03月01日 ページ情報: 英文
概要

世界のデジタルPCR(dPCR)およびリアルタイムPCR(qPCR)製品は、新型コロナウイルス感染症(COVID-19)の世界的大流行の影響で大きな需要が見込まれています。DNAポリメラーゼと呼ばれる酵素の働きを利用するPCRは、核酸を抽出しサンプル中のDNAやRNAの増幅する技術です。新型コロナウイルス感染症(COVID-19)が蔓延する中、PCR検査の信頼性がより高いことが確認されており、そのために世界中でPCR検査の普及が進んでいます。新型コロナウイルス感染症(COVID-19)の発生以前では、遺伝子疾患および感染症の罹患率の上昇や、官民による出資・助成金の増加、技術進歩、疾患診断におけるバイオマーカーの利用の増加、ヒトゲノム計画の完了などが主にデジタルPCRの成長を牽引していました。

当レポートでは、新型コロナウイルス感染症(COVID-19)のデジタルPCR業界への影響を調査し、市場の概要、法律と政策、消費者行動、マクロ経済的要因、市場影響要因の分析、地域別の収益予測、主要企業の動向およびプロファイルなどの情報をまとめています。

目次

第1章 レポート概要

  • 調査手法とツール

第2章 市場概要と考察

  • 調査範囲
  • アナリストの考察と現在の市場動向
    • 主な調査結果
    • 提言
    • 総論
  • 政府支援・支援策
  • 需給分析

第3章 市場概要

  • 新型コロナウイルス感染拡大の影響を除外したデジタルPCR業界の成長率
  • 新型コロナウイルス感染拡大の影響を考慮したデジタルPCR業界の成長率の差異

第4章 競合情勢

  • 企業シェアの分析
  • 主要戦略の分析
  • 主要企業の分析
    • 概要
    • 財務分析
    • SWOT分析
    • 近年の動向

第5章 市場セグメンテーション

  • 技術別
    • 定量PCR(qPCR)
    • デジタルPCR(dPCR)
  • 製品別
    • 装置
    • 試薬・消耗品
    • ソフトウェア・サービス

第6章 市場分析:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • その他
  • その他の地域

第7章 企業プロファイル

  • Abbott Laboratories Inc
  • Agilent Technologies, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Biosciences Inc.
  • BGI Group
  • Eppendorf AG
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Mylab Lifesolutions Pvt. Ltd.
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
図表

List of Tables

  • 1. GLOBAL dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY TECHNOLOGY 2018-2025 ($ MILLION)
  • 2. GLOBAL dPCR INDUSTRY RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 3. GLOBAL qPCR INDUSTRY RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 4. GLOBAL dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY PRODUCT 2018-2025 ($ MILLION)
  • 5. GLOBAL dPCR & qPCR INSTRUMENTS RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 6. GLOBAL dPCR & qPCR REAGENTS & CONSUMABLES RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 7. GLOBAL dPCR & qPCR SOFTWARE & SERVICES RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 8. NORTH AMERICA dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY TECHNOLOGY 2018-2025 ($ MILLION)
  • 9. NORTH AMERICA dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY PRODUCT 2018-2025 ($ MILLION)
  • 10. NORTH AMERICA dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY COUNTRY 2018-2025 ($ MILLION)
  • 11. EUROPE dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY TECHNOLOGY 2018-2025 ($ MILLION)
  • 12. EUROPE dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY PRODUCT 2018-2025 ($ MILLION)
  • 13. EUROPE dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY COUNTRY 2018-2025 ($ MILLION)
  • 14. ASIA PACIFIC dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY TECHNOLOGY 2018-2025 ($ MILLION)
  • 15. ASIA PACIFIC dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY PRODUCT 2018-2025 ($ MILLION)
  • 16. ASIA PACIFIC dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY COUNTRY 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY TECHNOLOGY 2018-2025 ($ MILLION)
  • 18. REST OF THE WORLD dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY PRODUCT 2018-2025 ($ MILLION)
  • 19. REST OF THE WORLD dPCR & qPCR INDUSTRY RESEARCH AND ANALYSIS, BY COUNTRY 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL dPCR & qPCR TREND PRE AND POST COVID-19, 2018-2025 (%)
  • 2. NORTH AMERICA DIGITAL PCRS TREND PRE AND POST COVID-19, 2018-2025 (%)
  • 3. EUROPE dPCR & qPCR TREND PRE AND POST COVID-19, 2018-2025 (%)
  • 4. ASIA PACIFIC dPCR & qPCR TREND PRE AND POST COVID-19, 2018-2025 (%)
  • 5. REST OF WORLD dPCR & qPCR TREND PRE AND POST COVID-19, 2018-2025 (%)
  • 6. US dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 7. CANADA dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 8. UK dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 9. GERMANY dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 10. FRANCE dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 11. SPAIN dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 12. ITALY dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 13. REST OF EUROPE dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 14. CHINA dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 15. JAPAN dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 16. INDIA dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
  • 17. REST OF ASIA PACIFIC dPCR & qPCR RESEARCH AND ANALYSIS 2018-2025 ($ MILLION)
目次
Product Code: OMR2021501

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report by Technology (Quantitative PCR and Digital PCR) by Product (Instruments, Reagents & Consumables, and Software & Services), Impact of COVID-19 on Global Digital PCR Industry, and Forecast 2019-2025

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) products is expected to show a huge demand due to the COVID-19 pandemic all across the globe. PCR that is polymer chain reaction is an approach used for the detection of nucleic acid detection in order to measure the quantity of DNA or RNA in any specific sample. Considering the current pandemic situation of the COVID-19 outbreak, the tests delivered using the PCR method are proved to be more reliable and hence the acceptance of PCR is rising across the globe.

The factors that were fueling the growth of the dPCR and qPCR market before pandemic include the rising incidences of target infectious diseases coupled with genetic disorders. Additionally, the continuous technological advancements in the field of PCR technologies due to the increasing investments, funds, and grants by the government as well as non-government organizations were also fuelling the market growth. Moreover, the increased use of biomarker profiling for disease diagnostics and their successful completion of the human genome project was a major factor for the growth of the market globally.

With the outbreak of COVID-19 since December 2019, the dPCR and qPCR products have shown some promising results for the diagnosis of the disease. The use of dPCR and qPCR for the screening is offering physicians various advantages such as less time consumption, and more reliable results. The industry report is segmented based on technology and product type. By technology, the report is bifurcated into quantitative PCR and digital PCR whereas by product, the industry is studied into instruments, reagents & consumables, and software & services. Exponential growth in the demand for instruments and reagents has been witnessed in the COVID-19 affected countries for the faster diagnosis of the infected patients.

The demand for dPCR and qPCR due to pandemic can be observed in all regions such as North America, Europe, Asia-Pacific and the Rest of the World. In January & February 2020, most of the demand was from Asia-Pacific, however, an exponential surge is witnessed in March 2020 in Europe and North America due to a sudden rise in the COVID-19 cases in these regions. In the US, the FDA took some additional significant diagnostic actions due to the COVID-19 outbreak. For instance, on 16 March 2020, the FDA issued Emergency Use Authorizations (EUAs) to Laboratory Corporation of America (LabCorp) for its COVID-19 RT-PCR test.

Key companies working in the market include Abbott Laboratories, Becton Dickinson and Co., Bio-Rad Laboratories Inc., Biosciences Inc., Eppendorf AG, F. Hoffmann-La Roche Ltd., and many more. Companies such as Bio-Rad are trying to come up with the authorized test to support the escalating need for testing across the globe. For instance, on 20th March 2020 Biodesix, Inc., a lung disease diagnostic company announced a partnership with Bio-Rad Laboratories, Inc. This partnership is done with the goal to bring a COVID-19 Droplet Digital PCR (ddPCR) test to the FDA for an Emergency Use Authorization (EUA) approval. On March 27, 2020, Abbott Laboratories got the US FDA approval for Abbott ID NOW platform which can diagnosis COVID-19 positive samples in 5 minutes and negative samples in 13 minutes.

Research Methodology

OMR global recently published a report addressing the impact of COVID-19 on the global dPCR and qPCR industry. The study is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data. Different approaches have been worked on to derive the market value and market growth rate. In the report, the analysis of the country is provided by analyzing various regional players, laws and policies, consumer behavior and macro-economic factors. The report includes analysis of different regions and countries and the effect of COVID-19 on the dPCR and qPCR industry of each respective region. Besides, an expected recovery timeline of the industry will also be included with the best- and worst-case scenario which will aid clients to take their future steps in the decision-making process.

Sources Include

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
  • Government Organizations Reports

The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

The Report Covers

  • Comprehensive research methodology of the global dPCR and qPCR Industry.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global dPCR and qPCR Industry.
  • Insights about market determinants that are stimulating the global Digital dPCR and qPCR Industry.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Government support/expenditure for the dPCR & qPCR
  • 2.4. Supply & Demand Analysis

3. Industry Overview

  • 3.1. Historical market growth estimation in dPCR & qPCR industry pre-COVID-19 pandemic
  • 3.2. Deviations in the dPCR & qPCR industry growth rate due to COVID-19 pandemic

4. Competitive Landscape

  • 4.1. Company Share Analysis
  • 4.2. Key Strategy Analysis
  • 4.3. Key Company Analysis
    • 4.3.1. Overview
    • 4.3.2. Financial Analysis
    • 4.3.3. SWOT Analysis
    • 4.3.4. Recent Developments

5. Market Segmentation

  • 5.1. By Technology
    • 5.1.1. Quantitative PCR (qPCR)
    • 5.1.2. Digital PCR (dPCR)
  • 5.2. By Product
    • 5.2.1. Instruments
    • 5.2.2. Reagents & Consumables
    • 5.2.3. Software & Services

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. Japan
    • 6.3.3. India
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc
  • 7.2. Agilent Technologies, Inc.
  • 7.3. Becton Dickinson and Company
  • 7.4. Bio-Rad Laboratories Inc.
  • 7.5. Biosciences Inc.
  • 7.6. BGI Group
  • 7.7. Eppendorf AG
  • 7.8. F. Hoffmann-La Roche Ltd.
  • 7.9. Merck KGaA
  • 7.10. Mylab Lifesolutions Pvt. Ltd.
  • 7.11. QIAGEN N.V.
  • 7.12. Thermo Fisher Scientific, Inc.